Accelerate to discover

Back to filter

Related topics

Intoducing cellenONE: The revolutionary Single Cell isolator

Cellenion

May 25, 2022

A revolutionary platform based on sciDROP PICO precision dispensing technology and coupled with advanced image...

Advances in Leukemia research using shear flow and Bioflux system

Fluxion Biosciences

May 24, 2022

Leukemia is a rare cancer with many subtypes. The production of abnormal leukocytes create disruptions in the immune...

Extracellular Vesicle Purity Enhanced by Gen 2 qEV Columns With Customised Proprietary Resin

IZON

May 4, 2022

Izon Science has announced the launch of Gen 2, the enhanced range of qEV columns for size-exclusion...

Why use Cytek Aurora?

Cytek Biosciences

May 3, 2022

A prodigy incorporating a unique combination of patent-pending innovative technologies that takes flow cytometry to the...

May 28, 2022

In-vivo webinar: a versatile use of SPECT/CT in the development of theranostic tracers

MOLECUBES

Mar 9, 2022

Combining (preclinical) imaging and targeted therapy, is the basis of theranostics. In this webinar, Dr. Florea will...

Introducing IsoPlexis Single-Cell Natural Killer Panel

IsoPlexis

Mar 4, 2022

Because of their ability to kill tumour cells, NK cells are an attractive target in cancer immunotherapy, therapeutic...

Enhanced small particle detection on CytekAurora and Northern Lights

Cytek Biosciences

Mar 2, 2022

Aurora system with ESP option, can fully resolve particles around 70nm and from the 80nm PS bead. The new violet laser...

May 28, 2022

Multi-modal PET drives interdisciplinary preclinical imaging

Bruker Biospin

Feb 23, 2022

Preclinical imaging (PCI) plays a vital role in understanding the biological processes behind disease states at the...

Show all topics (10)

Adhesion-based simple capture and recovery of circulating tumor cells using CQ1 imaging cytometer

Jan 24, 2018

Here, we explore the possibility of collecting CTCs using blood-compatible and thermo-responsive poly(2-(2-ethoxyethoxy) ethyl acrylate-co-2-(2-methoxyethoxy) ethyl methacrylate) (P(Et2A-Me2MA)) through adhesion and detachment by incubation under a lower critical solution temperature of P(Et2A-Me2MA). A P(Et2A-Me2MA)-coated substrate is dissolved by incubation under 15 °C. A P(Et2A-Me2MA)-coated substrate can suppress platelet adhesion whereas it allows the cancer cells to adhere by an epithelial cell adhesion molecule (EpCAM) expression-independent mechanism. These results suggest that cancer cells can specifically adhere to a P(Et2A-Me2MA)-coated substrate, which can be used to isolate CTCs from peripheral blood. Moreover, approximately 90% of the adherent cells can be detached by incubation at 10 and 15 °C for 30 and 90 min, respectively. The collected cells can be cultured healthily in the presence of dissolved P(Et2A-Me2MA), suggesting that the cytotoxicity of P(Et2A-Me2MA) is low. In conclusion, P(Et2A-Me2MA) is suitable for the development of devices that collect intact CTCs via an adhesion-based method.

Read more

 

Scientific paper
Application

Get more info

Riccardo Pasculli

Head of application support

Riccardo

Pasculli

+420 731 127 717

Send Message

Brand profile

Yokogawa

Yokogawa is a leading provider of confocal quantitative live cell imaging platforms. Combining superior technology with engineering services, project management, and maintenance, Yokogawa delivers field proven operational efficiency, safety, quality, and reliability. 

Related products

Confocal quantitative image cytometer CQ1 offers a new approach to image quantification

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey